DE Frankfurt Schmoll D: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
|MiPNetLab=Fischer S, Schlotte V | |MiPNetLab=Fischer S, Schlotte V | ||
|Status=O2k 2009- | |Status=O2k 2009- | ||
|info=[ | |info=[[IOC88]] | ||
|keywords= | |keywords= | ||
}} | }} | ||
== Power-O2k == | == Power-O2k == | ||
* [[DE Frankfurt Sanofi]] | * [[DE Frankfurt Sanofi]] |
Revision as of 11:16, 16 June 2016
DE Frankfurt Schmoll D
O2k-Network Lab | Sanofi-Aventis Deutschland GmbH
R&D TD Metabolism FFM |
---|---|
Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
City | Frankfurt |
State/Prov | |
Country | Germany |
Weblink | |
Contact | Schmoll D |
Team | Fischer S, Schlotte V |
Team previous | |
Status | O2k 2009- |
Oroboros Events | IOC88 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, BΓ³dis K, BΓ€renz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, MΓΌssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |
O2k-Abstracts
update please